Kala Visvanathan, M.D., M.H.S., from Johns Hopkins University in Baltimore, and colleagues on ASCO's Breast Cancer Risk Reduction Guideline Update Committee, conducted a literature review to identify randomized controlled trials and meta-analyses published from June 2007 through June 2012 with breast cancer incidence as the primary outcome of interest. The resulting updated American Society of Clinical Oncology (ASCO) clinical practice guideline appears in the Journal of Clinical Oncology. Read more here.
Study mentioned: Visvanathan K, et al. Use of Pharmacologic Interventions for Breast Cancer Risk Reduction: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2013 Jul 8. [Epub ahead of print] PMID: 23835710
No comments:
Post a Comment